A case report of individualized treatment of high risk and volume metastatic prostate cancer / 中华泌尿外科杂志
Chinese Journal of Urology
;
(12): 19-23, 2021.
Article
in Chinese
| WPRIM
| ID: wpr-911167
ABSTRACT
A 69-year old man presented with high-risk metastatic prostate cancer. After 7 months of androgen deprivation therapy (ADT), he progressed to metastatic castration resistant prostate cancer. We suggested him comprehensive therapy, including Abiraterone, chemo-therapy, radio-therapy, platinum chemo-therapy and Enzalutamide, which proved effective with his long term survival.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Etiology study
Language:
Chinese
Journal:
Chinese Journal of Urology
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS